PDS Biotechnology paid its 3 named executives $2.2M in total in FY2025 (Dec). CEO Frank Bedu-Addo, Ph.D. was paid $828.3K of that.
Pay$100 in the stock at the end of FY21 → $29
Pay of each named executive
Frank Bedu-Addo, Ph.D.Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
3 years
Kirk Shepard. M.D.Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Stephan ToutainChief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.